Back to AI Alyeska Investment Group, L.P.
PTGX3 quarters
Position history for AIAlyeska Investment Group, L.P.'s holdings in PROTAGONIST THERAPEUTICS INC
Alyeska Investment Group, L.P. holds 889,298 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $109M as of 2026-Q2. The position was increased (+49.9% shares). PTGX represents 0.3% of Alyeska Investment Group, L.P.'s portfolio.
Current Value
$109M
Current Shares
889,298
Total Value Change
+$91.6M
Total Shares Change
+689,775
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.